7
Orphan Designations
0
FDA Approvals
14
Rare Diseases
0
News Articles
| Disease | Drug(s) | Designation | Approved |
|---|---|---|---|
| B-cell chronic lymphocytic leukemia | oblimersen | Orphan Designation | - |
| Finnish type amyloidosis | tesetaxel | Orphan Designation | - |
| X-linked Alport syndrome | tesetaxel | Orphan Designation | - |
| acute myeloid leukemia | oblimersen | Orphan Designation | - |
| anal canal carcinoma in situ | tesetaxel | Orphan Designation | - |
| chronic myelogenous leukemia, BCR-ABL1 positive | c-myb antisense oligodeoxynucleotide | Orphan Designation | - |
| colorectal cancer | oblimersen | Orphan Designation | - |
| gastric cancer | tesetaxel | Orphan Designation | - |
| grade III prostatic intraepithelial neoplasia | tesetaxel | Orphan Designation | - |
| malignant mesothelioma | oblimersen | Orphan Designation | - |
| malignant peritoneal mesothelioma | oblimersen | Orphan Designation | - |
| plasma cell myeloma | oblimersen | Orphan Designation | - |
| squamous carcinoma in situ | tesetaxel | Orphan Designation | - |
| uterine cervix carcinoma in situ | tesetaxel | Orphan Designation | - |